Wednesday, 26 November 2014

The durability of sitagliptin in elderly patients with type 2 diabetes

Sitagliptin has a durable effect and stabilizes microvascular complication progression in elderly patients. This study can provide useful data for clinicians and health care professionals using sitagliptin monotherapy in the treatment of elderly patients with T2DM (Clinical Interventions in Aging)

No comments:

Post a Comment